pravastatin has been researched along with Hypertension in 116 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 29 (25.00) | 18.2507 |
| 2000's | 63 (54.31) | 29.6817 |
| 2010's | 22 (18.97) | 24.3611 |
| 2020's | 2 (1.72) | 2.80 |
| Authors | Studies |
|---|---|
| Costantine, MM; Eid, J; Rood, KM | 1 |
| Bu, X; Li, C; Liu, Y | 1 |
| Blaum, CS; Davis, BR; Han, BH; Pervin, H; Piller, LB; Pressel, SL; Sutin, D; Williamson, JD | 1 |
| Clark, JE; Garrett, N; Girardi, G; Pombo, J; Simmons, M; Umpierrez, M | 1 |
| Christopher-Stine, L; Isackson, PJ; Kitzmiller, JP; Luzum, JA; Ma, C; Nguyen, LM; Ochs-Balcom, HM; Peltier, W; Tarnopolsky, M; Vladutiu, GD; Weisman, M; Wortmann, RL | 1 |
| Bae, J; Kryzhanovski, VA; LeNarz, LA; Sponseller, CA; Zhao, Z; Zhu, Y | 1 |
| Banek, CT; Bauer, AJ; Capoccia, S; Gilbert, JS; Gillham, H; Needham, K; Regal, JF | 1 |
| Chertow, GM; Erickson, KF; Garber, AM; Goldhaber-Fiebert, JD; Japa, S; Owens, DK | 1 |
| Cagampang, FR; Elahi, MM; Hanson, MA; Ohri, SK | 1 |
| Bloch, MJ | 1 |
| Baimbridge, C; Ciocon, JO; Cuyjet, AB; Dart, RA; Davis, BR; Einhorn, PT; Ford, CE; Gordon, D; Hartney, TJ; Holtzman, J; Julian Haywood, L; Margolis, KL; Mathis, DE; Oparil, S; Probstfield, JL; Simpson, LM; Stokes, JD; Wiegmann, TB; Williamson, JD | 2 |
| Agarwal, V; Bangalore, S; Messerli, FH | 1 |
| Aleksandrowicz, M; Drapala, A; Kozniewska, E; Sikora, M; Skrzypecki, J; Ufnal, M; Zera, T | 1 |
| Medvedev, IN; Skoriatina, IA | 1 |
| Adams-Huet, B; Ahmad, Z; Khine, H; Yuet, WC | 1 |
| Baimbridge, C; Barzilay, J; Basile, JN; Davis, BR; Henriquez, MA; Huml, A; Kopyt, N; Louis, GT; Pressel, SL; Rahman, M; Rosendorff, C; Sastrasinh, S; Stanford, C | 1 |
| Admiraal-Behloul, F; Blauw, GJ; de Craen, AJ; van Buchem, MA; van der Grond, J; van Es, AC | 1 |
| Arima, S; Kai, T; Kanamasa, K; Nakabou, M; Taniyama, Y | 1 |
| Buckley, BM; de Craen, AJ; Ford, I; Gussekloo, J; Jukema, JW; Shepherd, J; Trompet, S; Westendorp, RG | 1 |
| Kushiro, T; Mizuno, K; Nakamura, H; Nakaya, N; Ohashi, Y; Tajima, N; Teramoto, T; Uchiyama, S | 2 |
| David, S; Fliser, D; Haller, H; Kielstein, JT; Kümpers, P; Lukasz, A | 1 |
| Arnett, DK; Boerwinkle, E; Cheng, S; Davis, BR; Eckfeldt, JH; Ford, CE; Leiendecker-Foster, C; Lynch, AI; Maitland-van der Zee, AH; Peters, BJ | 1 |
| Koh, KK | 1 |
| Kassan, M; Montero, MJ; Sevilla, MA | 1 |
| Lu, L; Wang, L; Zhang, TX; Zhou, JZ | 1 |
| David, S; Fliser, D; Haller, H; Kielstein, JT; Lorenzen, JM; Neunhöffer, H | 1 |
| Chang, NC; Chang, ST; Kang, CS; Lee, TM; Lin, CC | 1 |
| Kai, T; Kanamasa, K | 1 |
| Crow, RS; Davis, BR; Einhorn, PT; Ford, CE; Haywood, LJ; Massie, BM; Williard, A | 1 |
| Dunn, K; Einhorn, PT; Ford, CE; Gordon, DJ; Margolis, KL; Probstfield, JL; Simpson, LM; Williamson, JD | 1 |
| Bilo, G; Crepaldi, G; Giuliano, A; Mancia, G; Parati, G; Revera, M; Veglia, F; Zanchetti, A | 1 |
| Acharjee, S; Cannon, CP | 1 |
| Bangalore, S; Cannon, CP; Murphy, SA; Qin, J; Sloan, S | 1 |
| Cadnapaphornchai, MA; George, DM; Masoumi, A; McFann, K; Schrier, RW; Strain, JD | 1 |
| Kageji, T; Kanematsu, Y; Kinouchi, T; Kitazato, KT; Matsushita, N; Nagahiro, S; Satomi, J; Shimada, K; Tada, Y; Yagi, K | 1 |
| Iketani, T; Takazawa, K; Yamashina, A | 1 |
| Armstrong, PW; Borer, J; Lorell, BH; Nissen, S | 1 |
| Pasternak, RC | 1 |
| Traynor, K | 1 |
| Kulbertus, H; Scheen, AJ | 1 |
| Liebson, PR | 1 |
| Achimastos, A; Bairaktari, E; Elisaf, M; Ganotakis, E; Hasiotis, G; Kostoula, A; Mikhailidis, DP; Rizos, E | 1 |
| Diener, HC | 1 |
| Liakishev, AA | 1 |
| Brown, WV; Moussa, M | 1 |
| Arai, H; Matsuo, K; Miura, S; Nishikawa, H; Saku, K; Shimomura, H; Tsuchiya, Y; Zhang, B | 1 |
| Gomi, T; Ikeda, T; Kobayashi, S; Matsuo, K; Moriya, H; Nakayama, D; Sakurai, J; Shibuya, Y; Takahashi, Y | 1 |
| Ford, I; Lowe, GD; McMahon, AD; O'Reilly, DS; Packard, CJ; Rumley, A | 1 |
| Pasternak, RC; Skerrett, PJ | 1 |
| Buchholz, K; Fliser, D; Haller, H | 1 |
| Hayashi, M; Ichihara, A; Kaneshiro, Y; Koura, Y; Saruta, T; Tada, Y | 1 |
| Baggio, G; Bond, MG; Crepaldi, G; Gallus, G; Magni, A; Mancia, G; Rubba, P; Sampieri, L; Sperti, G; Veglia, F; Ventura, A; Zanchetti, A | 1 |
| Cartwright, MS; Donofrio, PD; Jeffery, DR; Nuss, GR | 1 |
| Bezerra, DG; Mandarim-de-Lacerda, CA | 1 |
| Chang, NC; Chou, TF; Lee, TM; Lin, MS; Tsai, CH | 1 |
| Field, KM | 1 |
| Anazawa, T; Furukawa, K; Kanmatsuse, K; Kawamata, H; Kushiro, T; Nagao, K; Sato, Y; Tachibana, E; Tani, S; Watanabe, I | 1 |
| Fomin, VV; Moiseev, SV | 1 |
| Ando, K; Fujita, T; Kido, M; Oba, S | 1 |
| Carod-Artal, FJ | 1 |
| Kawano, H; Yano, K | 1 |
| Dong, YF; Kataoka, K; Kim-Mitsuyama, S; Lai, ZF; Matsuba, S; Ogawa, H; Tanaka, T; Tokutomi, Y; Yamamoto, E; Yamashita, T | 1 |
| Arnett, DK; Boerwinkle, E; Davis, BR; Eckfeldt, JH; Ford, CE; Klungel, OH; Leiendecker-Foster, C; Maitland-van der Zee, AH; Miller, MB | 1 |
| Campesi, I; Emanueli, C; Gadau, S; Kraenkel, N; Madeddu, P; Meloni, M; Monopoli, A; Ongini, E | 1 |
| Akino, M; Matsui, Y; Okamoto, H; Onozuka, H; Tsutsui, H; Xu, Z | 1 |
| Cappelleri, JC; Dubois, RW; Messerli, FH; Pinto, L; Sichrovsky, T; Tang, SS; Thakker, KM | 1 |
| Anthony, FW; Cagampang, FR; Curzen, N; Elahi, MM; Hanson, MA; Ohri, SK | 1 |
| Criqui, MH; Dimsdale, JE; Golomb, BA; Ritchie, JB; White, HL | 1 |
| Balestrieri, GP; Cerudelli, B; Giustina, G; Marocolo, D; Scalvini, T; Sleiman, I | 1 |
| Conway, EL; Howes, LG; Krum, H; Lam, W; Louis, WJ; O'Callaghan, CJ; Skiba, MA | 2 |
| Howes, LG; Lam, W; Louis, WJ; Straznicky, NE | 1 |
| Amery, A; Celis, H; Fagard, R; Lijnen, P; Staessen, J; Thijs, L | 1 |
| Otsuka, K; Tsukiyama, H | 1 |
| Baba, T; Ishizaki, T; Kodama, T; Yajima, Y | 1 |
| Chan, P; Ko, JT; Lee, CB; Lee, YS; Lin, TS; Pan, WH | 1 |
| Darioli, R; Greminger, P; Riesen, W; Simeon-Dubach, D; Waeber, B; Wunderlin, R | 1 |
| Ikeda, K; Li, N; Nara, Y; Sawamura, M; Yamori, Y | 1 |
| Chan, P; Lee, CB; Lee, YS; Pan, WH; Tomlinson, B | 1 |
| Arsenescu, I; Provendier, O; Witchitz, S | 1 |
| Cicco, G; Pirrelli, A; van der Kleij, AJ; Vicenti, P | 1 |
| Barrett e Pesquisadores, AC | 1 |
| Zanchetti, A | 1 |
| Kobashigawa, JA | 1 |
| Alonso-Galicia, M; Roman, RJ; Wilson, TW | 1 |
| Smit, AJ | 1 |
| Chua, TP; Fox, KM; Saia, F | 1 |
| Coelho, OR; Mansur, AP; Nicolau, JC; Ramires, JA; Spósito, AC | 1 |
| Foss, OP; Graff-Iversen, S; Graving, B; Istad, H; Søyland, E; Tjeldflaat, L | 1 |
| Gotto, AM | 1 |
| Abe, K; Imai, Y; Saito, T; Saruta, T; Suzuki, H; Tsuji, I | 1 |
| Collatina, S; Dettori, F; Filigheddu, F; Glorioso, N; Pahor, M; Parpaglia, PP; Soro, A; Troffa, C | 1 |
| Cicco, G; Pirrelli, A; Stingi, GD; Tarallo, MS; van der Kleij, AJ | 1 |
| Cicco, G; Pirrelli, A; Stingi, GD; Tarallo, MS; Vicenti, P | 1 |
| Ambrosioni, E; Bacchelli, S; Borghi, C; Costa, FV; Degli Esposti, D; Prandin, MG | 1 |
| Chisholm, DJ; Greenfield, JR | 1 |
| Cockcroft, JR; Wilkinson, IB | 1 |
| Chu, CW; Hsiao, CL; Lee, BC; Lee, TM; Su, SF | 1 |
| Celesia, GG; Kellman, W; Ruosseau, P; Siegel, G; Wolozin, B | 1 |
| Bettencourt, J; Davis, BR; Ford, CE; Furberg, CD; Geraci, TS; Kimmel, B; Kingry, C; Lusk, C; Nwachuku, C; Parks, H; Piller, LB; Pressel, SL; Simpson, LM; Wright, JT | 1 |
| Baggio, G; Bond, MG; Collatina, S; Crepaldi, G; Gallus, GV; Mancia, G; Rubba, P; Sampieri, L; Serrotti, E; Veglia, F; Ventura, A; Zanchetti, A | 1 |
| Barzilay, JI; Basile, JN; Ciocon, JO; Davis, BR; Goff, DC; Jones, CL; Randall, OS; Sweeney, ME | 1 |
| Guthrie, RM | 1 |
| Dumont, AS; Dumont, RJ; Fedak, PM; Hyndman, ME; Kassell, NF; Sutherland, GR; Verma, S | 1 |
| Ichihara, K; Kaneta, S; Marumo, H; Satoh, K; Yamamoto, A | 1 |
| Lee, TM; Su, SF; Tsai, CH | 1 |
| Do, GM; Kwon, O; Lee, S; Lim, Y; Park, SY; Shin, JH | 1 |
12 review(s) available for pravastatin and Hypertension
| Article | Year |
|---|---|
Aspirin and Pravastatin for Preeclampsia Prevention in High-Risk Pregnancy.
Topics: Aspirin; Female; Humans; Hypertension; Infant, Newborn; Pravastatin; Pre-Eclampsia; Pregnancy; Pregnancy, High-Risk | 2023 |
Cost-effectiveness of statins for primary cardiovascular prevention in chronic kidney disease.
Topics: Aged; Cost-Benefit Analysis; Decision Support Techniques; Disease Progression; Drug Costs; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Kidney Failure, Chronic; Male; Markov Chains; Myocardial Infarction; Pravastatin; Primary Prevention; Quality-Adjusted Life Years; Rhabdomyolysis; Risk; Sex Factors; Stroke; United States | 2013 |
Office-based global cardiometabolic risk assessment: a simple tool incorporating nontraditional markers.
Topics: Atorvastatin; Biomarkers; Cardiovascular Diseases; Clinical Trials as Topic; Female; Heptanoic Acids; Humans; Hypercholesterolemia; Hypertension; Male; Obesity; Office Visits; Practice Patterns, Physicians'; Pravastatin; Pyrroles; Risk Assessment; Smoking; United States | 2010 |
Perspectives from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial--Lipid Lowering Trial and the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm.
Topics: Aged; Atorvastatin; Cholesterol, LDL; Coronary Artery Disease; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Male; Middle Aged; Myocardial Infarction; Pravastatin; Pyrroles; Randomized Controlled Trials as Topic; Stroke; Treatment Outcome | 2003 |
ALLHAT-LLT: questions, questions, and more questions (and some answers).
Topics: Aged; Cardiovascular Diseases; Cholesterol, LDL; Clinical Trials as Topic; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypertension; Male; Middle Aged; Pravastatin; Risk | 2004 |
Effect of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on high-sensitivity C-reactive protein levels.
Topics: Animals; Atherosclerosis; Atorvastatin; C-Reactive Protein; Cardiovascular Diseases; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Metabolic Syndrome; Pravastatin; Pyrroles; Risk Factors; Simvastatin | 2005 |
[Hypertension combined with atherosclerotic lesions in carotid arteries: should angiotensin converting enzyme inhibitors be prescribed?].
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anticholesteremic Agents; Antihypertensive Agents; Atenolol; Calcium Channel Blockers; Carotid Artery Diseases; Carotid Artery, Common; Chlorthalidone; Drug Therapy, Combination; Female; Fosinopril; Humans; Hypertension; Male; Middle Aged; Pravastatin; Randomized Controlled Trials as Topic; Risk Factors; Time Factors; Ultrasonography; Vasodilator Agents; Verapamil | 2005 |
Impact of systemic hypertension on the cardiovascular benefits of statin therapy--a meta-analysis.
Topics: Aged; Atorvastatin; Cardiovascular Diseases; Fatty Acids, Monounsaturated; Female; Fluvastatin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Indoles; Male; Middle Aged; Pravastatin; Prognosis; Pyrroles; Randomized Controlled Trials as Topic; Simvastatin; Therapeutics | 2008 |
The hypertensive patient with multiple risk factors: is treatment really so difficult?
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Animals; Anticholesteremic Agents; Antihypertensive Agents; Arteriosclerosis; Clinical Trials as Topic; Coronary Disease; Female; Fosinopril; Humans; Hydrochlorothiazide; Hypercholesterolemia; Hypertension; Male; Middle Aged; Pravastatin; Risk Factors | 1997 |
Targeting nonalloimmune-dependent pathways.
Topics: Antihypertensive Agents; Coronary Artery Bypass; Coronary Disease; Diltiazem; Heart Transplantation; Humans; Hypertension; Immunosuppressive Agents; Photopheresis; Postoperative Complications; Pravastatin; Reoperation; Risk Factors | 1997 |
Vastatin trials: lessons from hypertension history.
Topics: Aged; Anticholesteremic Agents; Controlled Clinical Trials as Topic; Humans; Hypertension; Pravastatin; Simvastatin; Treatment Outcome | 1998 |
Hemorheology and tissue oxygenation in hypertensives with lipoidoproteinosis and peripheral occlusive arterial disease (POAD) treated with sulodexide and pravastatine and evaluated with laser assisted optical rotational red cell analyzer (LORCA) and trans
Topics: Adult; Aged; Blood Gas Monitoring, Transcutaneous; Female; Glycosaminoglycans; Hemorheology; Humans; Hypercholesterolemia; Hyperlipidemias; Hypertension; Hypolipidemic Agents; Laser-Doppler Flowmetry; Lasers; Lipoid Proteinosis of Urbach and Wiethe; Male; Middle Aged; Peripheral Vascular Diseases; Pravastatin | 1999 |
54 trial(s) available for pravastatin and Hypertension
| Article | Year |
|---|---|
Effect of Statin Treatment vs Usual Care on Primary Cardiovascular Prevention Among Older Adults: The ALLHAT-LLT Randomized Clinical Trial.
Topics: Aged; Antihypertensive Agents; Cardiovascular Diseases; Cholesterol, LDL; Drug Monitoring; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypertension; Male; Medication Therapy Management; Outcome and Process Assessment, Health Care; Pravastatin; Primary Prevention; United States | 2017 |
Long-term follow-up of moderately hypercholesterolemic hypertensive patients following randomization to pravastatin vs usual care: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT).
Topics: Aged; Anticholesteremic Agents; Black People; Cohort Studies; Coronary Disease; Female; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypertension; Kidney Failure, Chronic; Male; Middle Aged; Patient Compliance; Pravastatin; Risk Factors; Treatment Outcome | 2013 |
Progression of kidney disease in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin versus usual care: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Topics: Aged; Anticholesteremic Agents; Cholesterol; Disease Progression; Female; Glomerular Filtration Rate; Humans; Hypercholesterolemia; Hypertension; Incidence; Kidney Diseases; Kidney Failure, Chronic; Male; Middle Aged; Pravastatin; Treatment Outcome | 2008 |
Risk factors for cerebral microbleeds in the elderly.
Topics: Age Distribution; Aged; Aged, 80 and over; Anticholesteremic Agents; Basal Ganglia Cerebrovascular Disease; Female; Humans; Hypertension; Intracranial Hemorrhages; Magnetic Resonance Imaging; Male; Pravastatin; Prevalence; Risk Factors | 2008 |
Comparison of the effect of lipophilic and hydrophilic statins on serum adiponectin levels in patients with mild hypertension and dyslipidemia: Kinki Adiponectin Interventional (KAI) Study.
Topics: Adiponectin; Adipose Tissue; Adult; Aged; Aged, 80 and over; C-Reactive Protein; Cholesterol; Dyslipidemias; Female; Humans; Hydrophobic and Hydrophilic Interactions; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Male; Middle Aged; Pravastatin; Prospective Studies; Simvastatin | 2008 |
Pravastatin for cardiovascular event primary prevention in patients with mild-to-moderate hypertension in the Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese (MEGA) Study.
Topics: Aged; Anticholesteremic Agents; Blood Pressure; Cardiovascular Diseases; Cerebral Infarction; Cholesterol; Combined Modality Therapy; Coronary Disease; Diet; Dyslipidemias; Female; Follow-Up Studies; Humans; Hypertension; Incidence; Japan; Male; Middle Aged; Pravastatin; Severity of Illness Index | 2009 |
Circulating angiopoietin-2 in essential hypertension: relation to atherosclerosis, vascular inflammation, and treatment with olmesartan/pravastatin.
Topics: Adult; Aged; Angiopoietin-2; Angiotensin II Type 1 Receptor Blockers; Atherosclerosis; C-Reactive Protein; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Imidazoles; Male; Middle Aged; Pravastatin; Prospective Studies; Tetrazoles; Vasculitis | 2009 |
The effect of nine common polymorphisms in coagulation factor genes (F2, F5, F7, F12 and F13 ) on the effectiveness of statins: the GenHAT study.
Topics: Aged; Blood Coagulation Factors; Coronary Disease; Drug Resistance; Female; Genetic Predisposition to Disease; Genotype; Humans; Hypertension; Hypolipidemic Agents; Linkage Disequilibrium; Male; Middle Aged; Polymorphism, Single Nucleotide; Pravastatin; Treatment Outcome | 2009 |
Effects of Xuezhikang and pravastatin on circulating endothelial progenitor cells in patients with essential hypertension.
Topics: Aged; Anticholesteremic Agents; Antidiuretic Agents; Antihypertensive Agents; Blood Cell Count; Calcium Channel Blockers; Cell Adhesion; Cell Proliferation; Cells, Cultured; Drug Therapy, Combination; Drugs, Chinese Herbal; Endothelial Cells; Female; Humans; Hypertension; Integrative Medicine; Male; Middle Aged; Pravastatin; Stem Cells | 2009 |
Effects of increasing the dose of pravastatin on serum adiponectin level in Japanese mild hypercholesterolemic and hypertensive patients.
Topics: Adiponectin; Aged; Aged, 80 and over; Blood Pressure; C-Reactive Protein; Cholesterol, LDL; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypertension; Japan; Lipids; Male; Middle Aged; Pravastatin; Prospective Studies | 2009 |
Atrial fibrillation at baseline and during follow-up in ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial).
Topics: Antihypertensive Agents; Atrial Fibrillation; Atrial Flutter; Comorbidity; Doxazosin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Incidence; Kaplan-Meier Estimate; Myocardial Infarction; Pravastatin; Prognosis; Smoking | 2009 |
Coronary heart disease in moderately hypercholesterolemic, hypertensive black and non-black patients randomized to pravastatin versus usual care: the antihypertensive and lipid lowering to prevent heart attack trial (ALLHAT-LLT).
Topics: Aged; Antihypertensive Agents; Black or African American; Coronary Disease; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypertension; Hypolipidemic Agents; Male; Middle Aged; Pravastatin; Severity of Illness Index | 2009 |
Statins, antihypertensive treatment, and blood pressure control in clinic and over 24 hours: evidence from PHYLLIS randomised double blind trial.
Topics: Aged; Anticholesteremic Agents; Antihypertensive Agents; Blood Pressure Determination; Drug Therapy, Combination; Female; Fosinopril; Humans; Hydrochlorothiazide; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypertension; Italy; Male; Middle Aged; Pravastatin | 2010 |
What is the optimal blood pressure in patients after acute coronary syndromes?: Relationship of blood pressure and cardiovascular events in the PRavastatin OR atorVastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction (PROVE IT-TI
Topics: Acute Coronary Syndrome; Adult; Aged; Anticholesteremic Agents; Atorvastatin; Blood Pressure; Female; Follow-Up Studies; Heptanoic Acids; Humans; Hypertension; Incidence; Male; Middle Aged; Myocardial Infarction; Pravastatin; Prognosis; Proportional Hazards Models; Pyrroles; Risk Factors; Thrombolytic Therapy; Treatment Outcome | 2010 |
Effect of statin therapy on disease progression in pediatric ADPKD: design and baseline characteristics of participants.
Topics: Adolescent; Adult; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Child; Disease Progression; Double-Blind Method; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Hypertrophy, Left Ventricular; Kidney; Lisinopril; Male; Polycystic Kidney, Autosomal Dominant; Pravastatin; Renin-Angiotensin System; Young Adult | 2011 |
Effect of eicosapentaenoic acid on central systolic blood pressure.
Topics: Blood Pressure; Eicosapentaenoic Acid; Female; Humans; Hyperlipidemias; Hypertension; Male; Middle Aged; Pravastatin | 2013 |
Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT).
Topics: Aged; Anticholesteremic Agents; Cardiovascular Diseases; Cause of Death; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypertension; Lipids; Male; Middle Aged; Pravastatin; Proportional Hazards Models; Risk Factors | 2002 |
[Clinical study of the month. The ALLHAT-LLT trial].
Topics: Aged; Anticholesteremic Agents; Cardiovascular Diseases; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypertension; Male; Pravastatin; Randomized Controlled Trials as Topic; Risk Factors | 2003 |
LIFE and ARBITER.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Atenolol; Atorvastatin; Carotid Artery Diseases; Cholesterol, LDL; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Hypertrophy, Left Ventricular; Losartan; Pravastatin; Pyrroles; Treatment Outcome | 2003 |
The combination of nebivolol plus pravastatin is associated with a more beneficial metabolic profile compared to that of atenolol plus pravastatin in hypertensive patients with dyslipidemia: a pilot study.
Topics: Adrenergic beta-Antagonists; Anticholesteremic Agents; Atenolol; Benzopyrans; Drug Therapy, Combination; Ethanolamines; Female; Humans; Hyperlipidemias; Hypertension; Male; Nebivolol; Pilot Projects; Pravastatin | 2003 |
Pravastatin has an additional depressor effect in patients undergoing long-term treatment with antihypertensive drugs.
Topics: Adult; Aged; Aged, 80 and over; Anticholesteremic Agents; Antihypertensive Agents; Apolipoproteins B; Biomarkers; Blood Pressure; Cholesterol, LDL; Creatine Kinase; Cross-Over Studies; Diastole; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Japan; Male; Middle Aged; Pravastatin; Systole; Time; Transaminases; Treatment Outcome | 2004 |
Interleukin-6, fibrin D-dimer, and coagulation factors VII and XIIa in prediction of coronary heart disease.
Topics: Angioplasty, Balloon, Coronary; Biomarkers; Case-Control Studies; Coronary Disease; Factor VII; Factor XIIa; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypertension; Incidence; Inflammation; Interleukin-6; Male; Middle Aged; Monocytes; Myocardial Infarction; Myocardial Revascularization; Pravastatin; Predictive Value of Tests; Risk Factors; Scotland; Thrombophilia; Triglycerides | 2004 |
Antiinflammatory effects of angiotensin II subtype 1 receptor blockade in hypertensive patients with microinflammation.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Arteriosclerosis; Biomarkers; C-Reactive Protein; Chemokine CCL2; Cholesterol; Comorbidity; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Imidazoles; Intercellular Adhesion Molecule-1; Interleukin-6; Lipids; Male; Middle Aged; Olmesartan Medoxomil; Pravastatin; Prospective Studies; Receptor, Angiotensin, Type 1; Tetrazoles; Treatment Outcome; Tumor Necrosis Factor-alpha; Vasculitis | 2004 |
Long-term effects of statins on arterial pressure and stiffness of hypertensives.
Topics: Anticholesteremic Agents; Arteriosclerosis; Blood Pressure; C-Reactive Protein; Cholesterol; Elasticity; Fatty Acids, Monounsaturated; Female; Fluvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemias; Hypertension; Indoles; Male; Middle Aged; Pravastatin; Prospective Studies; Pulsatile Flow; Simvastatin; Single-Blind Method | 2005 |
Different effects of antihypertensive regimens based on fosinopril or hydrochlorothiazide with or without lipid lowering by pravastatin on progression of asymptomatic carotid atherosclerosis: principal results of PHYLLIS--a randomized double-blind trial.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Anticholesteremic Agents; Antihypertensive Agents; Carotid Stenosis; Disease Progression; Diuretics; Drug Therapy, Combination; Female; Fosinopril; Humans; Hydrochlorothiazide; Hypercholesterolemia; Hypertension; Male; Middle Aged; Pravastatin; Sodium Chloride Symporter Inhibitors | 2004 |
Effect of pravastatin on malondialdehyde-modified low-density lipoprotein levels and coronary plaque regression as determined by three-dimensional intravascular ultrasound.
Topics: Anticholesteremic Agents; Cholesterol; Coronary Disease; Diabetes Mellitus; Female; Humans; Hypertension; Lipoproteins, LDL; Male; Malondialdehyde; Middle Aged; Pravastatin; Risk Factors; Smoking; Ultrasonography | 2005 |
Pravastatin decreases blood pressure in hypertensive and hypercholesterolemic patients receiving antihypertensive treatment.
Topics: Adult; Aged; Anticholesteremic Agents; Blood Pressure; Cholesterol, LDL; Female; Humans; Hypercholesterolemia; Hypertension; Male; Middle Aged; Pravastatin; Retrospective Studies | 2006 |
Reduction in blood pressure with statins: results from the UCSD Statin Study, a randomized trial.
Topics: Antihypertensive Agents; Blood Pressure; Cardiovascular Diseases; Diastole; Double-Blind Method; Female; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Male; Pravastatin; Simvastatin; Stroke; Systole; Treatment Outcome | 2008 |
Short term effects of pravastatin on blood pressure in hypercholesterolaemic hypertensive patients.
Topics: Blood Pressure; Captopril; Cholesterol; Cholesterol, LDL; Combined Modality Therapy; Double-Blind Method; Drug Interactions; Felodipine; Female; Humans; Hypercholesterolemia; Hypertension; Lipids; Male; Middle Aged; Pravastatin | 1994 |
Efficacy of pravastatin in combination with captopril in hypertensive patients.
Topics: Adult; Aged; Analysis of Variance; Captopril; Cholesterol; Double-Blind Method; Drug Therapy, Combination; Humans; Hypercholesterolemia; Hypertension; Middle Aged; Pravastatin; Treatment Outcome | 1995 |
Effects of pravastatin on cardiovascular reactivity to norepinephrine and angiotensin II in patients with hypercholesterolemia and systemic hypertension.
Topics: Adult; Aged; Angiotensin II; Blood Pressure; Cardiovascular System; Cholesterol; Cross-Over Studies; Double-Blind Method; Female; Humans; Hypercholesterolemia; Hypertension; Male; Middle Aged; Norepinephrine; Pravastatin; Treatment Outcome | 1995 |
Efficacy and safety of pravastatin in hypertensive hypercholesterolaemic patients on antihypertensive drug therapy.
Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Cholesterol; Double-Blind Method; Drug Interactions; Female; Humans; Hypercholesterolemia; Hypertension; Lipoproteins, HDL; Lipoproteins, LDL; Male; Middle Aged; Patient Compliance; Pravastatin | 1994 |
Plaque Hypertension Lipid-Lowering Italian Study (PHYLLIS): a protocol for non-invasive evaluation of carotid atherosclerosis in hypercholesterolaemic hypertensive subjects.
Topics: Aged; Arteriosclerosis; Carotid Artery Diseases; Clinical Protocols; Double-Blind Method; Female; Fosinopril; Humans; Hypercholesterolemia; Hypertension; Italy; Male; Middle Aged; Pravastatin; Ultrasonography | 1993 |
Effects of pravastatin in patients with serum total cholesterol levels from 5.2 to 7.8 mmol/liter (200 to 300 mg/dl) plus two additional atherosclerotic risk factors. The Pravastatin Multinational Study Group for Cardiac Risk Patients.
Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Cardiovascular Diseases; Double-Blind Method; Female; Humans; Hypercholesterolemia; Hypertension; Life Tables; Male; Middle Aged; Myocardial Infarction; Pravastatin; Risk Factors; Smoking; Treatment Outcome | 1993 |
Effects of pravastatin, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, on glucose tolerance in patients with essential hypertension.
Topics: Adult; Blood Glucose; Blood Pressure; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Glucose Tolerance Test; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Middle Aged; Pravastatin; Triglycerides | 1993 |
The effectiveness and safety of low dose pravastatin in elderly hypertensive hypercholesterolemic subjects on antihypertensive therapy.
Topics: Aged; Anticholesteremic Agents; Antihypertensive Agents; Cholesterol, HDL; Cholesterol, LDL; Double-Blind Method; Female; Humans; Hypercholesterolemia; Hypertension; Male; Patient Compliance; Placebos; Pravastatin | 1995 |
Combined treatment with captopril, hydrochlorothiazide and pravastatin in dyslipidemic hypertensive patients.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Anticholesteremic Agents; Antihypertensive Agents; Captopril; Combined Modality Therapy; Diuretics; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Hydrochlorothiazide; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypertension; Male; Middle Aged; Pravastatin; Prospective Studies; Sodium Chloride Symporter Inhibitors | 1995 |
Beneficial effects of pravastatin on fasting hyperinsulinemia in elderly hypertensive hypercholesterolemic subjects.
Topics: Aged; Aged, 80 and over; Anticholesteremic Agents; Cholesterol, HDL; Double-Blind Method; Female; Humans; Hypercholesterolemia; Hyperinsulinism; Hypertension; Male; Patient Compliance; Pravastatin; Prospective Studies | 1996 |
West of Scotland Coronary Prevention Study: identification of high-risk groups and comparison with other cardiovascular intervention trials.
Topics: Anticholesteremic Agents; Antihypertensive Agents; Cerebrovascular Disorders; Coronary Disease; Humans; Hyperlipidemias; Hypertension; Male; Middle Aged; Pravastatin; Risk; Scotland | 1996 |
[Comparative effects of captopril and atenolol on lipid metabolism in hypertensive hypercholesterolemic patients treated with pravastatin. A multicenter controlled trial].
Topics: Adult; Aged; Anticholesteremic Agents; Antihypertensive Agents; Atenolol; Captopril; Double-Blind Method; Female; Humans; Hypercholesterolemia; Hypertension; Lipid Metabolism; Male; Middle Aged; Pravastatin; Time Factors | 1996 |
[Pravastatin multicenter clinical trial in patients with hypercholesterolemia and multiple risk factors].
Topics: Adolescent; Adult; Aged; Analysis of Variance; Anticholesteremic Agents; Diabetes Complications; Female; Humans; Hypercholesterolemia; Hypertension; Male; Menopause; Middle Aged; Obesity; Pravastatin; Risk Factors; Sex Factors; Smoking | 1997 |
The hypertensive patient with multiple risk factors: is treatment really so difficult?
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Animals; Anticholesteremic Agents; Antihypertensive Agents; Arteriosclerosis; Clinical Trials as Topic; Coronary Disease; Female; Fosinopril; Humans; Hydrochlorothiazide; Hypercholesterolemia; Hypertension; Male; Middle Aged; Pravastatin; Risk Factors | 1997 |
Additional reduction in blood pressure after cholesterol-lowering treatment by statins (lovastatin or pravastatin) in hypercholesterolemic patients using angiotensin-converting enzyme inhibitors (enalapril or lisinopril).
Topics: Angiotensin-Converting Enzyme Inhibitors; Anticholesteremic Agents; Blood Pressure; Drug Interactions; Enalapril; Female; Heart Rate; Humans; Hypercholesterolemia; Hypertension; Lisinopril; Lovastatin; Male; Middle Aged; Pravastatin | 1999 |
Treatment of hypertensive and hypercholesterolaemic patients in general practice. The effect of captopril, atenolol and pravastatin combined with life style intervention.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anticholesteremic Agents; Atenolol; Captopril; Combined Modality Therapy; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypercholesterolemia; Hypertension; Life Style; Male; Middle Aged; Norway; Pravastatin; Statistics, Nonparametric | 1999 |
Lipid management in patients at moderate risk for coronary heart disease: insights from the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS).
Topics: Age Factors; Aged; Anticholesteremic Agents; Coronary Artery Disease; Coronary Disease; Diabetes Mellitus, Type 2; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Lovastatin; Male; Middle Aged; Military Personnel; Practice Guidelines as Topic; Pravastatin; Primary Prevention; Risk; Risk Factors; Sex Factors; Smoking; Texas; Treatment Outcome | 1999 |
The effect of pravastatin on renal function and lipid metabolism in patients with renal dysfunction with hypertension and hyperlipidemia. Pravastatin and Renal Function Research Group.
Topics: Blood Urea Nitrogen; Calcium Channel Blockers; Cholesterol; Creatinine; Dihydropyridines; Drug Therapy, Combination; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypertension; Kidney Diseases; Male; Middle Aged; Pravastatin; Treatment Outcome | 1999 |
Effect of the HMG-CoA reductase inhibitors on blood pressure in patients with essential hypertension and primary hypercholesterolemia.
Topics: Adult; Aged; Blood Pressure; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cold Temperature; Cross-Over Studies; Double-Blind Method; Endothelins; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypertension; Male; Middle Aged; Pravastatin; Treatment Outcome | 1999 |
Use of statins and blood pressure control in treated hypertensive patients with hypercholesterolemia.
Topics: Adult; Aged; Anticholesteremic Agents; Antihypertensive Agents; Blood Pressure; Female; Humans; Hypercholesterolemia; Hypertension; Male; Middle Aged; Pravastatin; Simvastatin | 2000 |
Effects of pravastatin on left ventricular mass in patients with hyperlipidemia and essential hypertension.
Topics: Echocardiography; Female; Heart Ventricles; Hemodynamics; Humans; Hyperlipidemias; Hypertension; Linear Models; Male; Middle Aged; Pravastatin | 2000 |
Operational aspects of terminating the doxazosin arm of The Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Topics: Adverse Drug Reaction Reporting Systems; Antihypertensive Agents; Cause of Death; Coronary Disease; Databases, Factual; Double-Blind Method; Doxazosin; Female; Heart Failure; Humans; Hypercholesterolemia; Hypertension; Male; Middle Aged; Myocardial Infarction; Pravastatin; Risk Assessment; Survival Rate; Treatment Outcome; United States | 2001 |
Systolic and pulse blood pressures (but not diastolic blood pressure and serum cholesterol) are associated with alterations in carotid intima-media thickness in the moderately hypercholesterolaemic hypertensive patients of the Plaque Hypertension Lipid Lo
Topics: Angiotensin-Converting Enzyme Inhibitors; Anticholesteremic Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Carotid Arteries; Cholesterol; Disease Progression; Drug Therapy, Combination; Female; Fosinopril; Heart Rate; Humans; Hypercholesterolemia; Hypertension; Italy; Male; Middle Aged; Pravastatin; Systole; Tunica Intima; Ultrasonography | 2001 |
Baseline characteristics of the diabetic participants in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Cholesterol, Dietary; Cohort Studies; Coronary Disease; Double-Blind Method; Doxazosin; Ethnicity; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypertension; Lisinopril; Male; Middle Aged; Myocardial Infarction; Pravastatin; Racial Groups; Risk Factors; United States | 2001 |
The effects of postal and telephone reminders on compliance with pravastatin therapy in a national registry: results of the first myocardial infarction risk reduction program.
Topics: Anticholesteremic Agents; Cholesterol; Communication; Female; Humans; Hypertension; Life Style; Male; Middle Aged; Myocardial Infarction; Patient Compliance; Patient Education as Topic; Pravastatin; Risk Factors; Surveys and Questionnaires; Telephone | 2001 |
Effect of pravastatin on proteinuria in patients with well-controlled hypertension.
Topics: Adult; Double-Blind Method; Endothelin-1; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Lipids; Male; Middle Aged; Multivariate Analysis; Pravastatin; Prospective Studies; Proteinuria; Treatment Outcome | 2002 |
51 other study(ies) available for pravastatin and Hypertension
| Article | Year |
|---|---|
Effect of folic acid combined with pravastatin on arteriosclerosis in elderly hypertensive patients with lacunar infarction.
Topics: Aged; Aged, 80 and over; Anticholesteremic Agents; Antihypertensive Agents; Arteriosclerosis; Blood Pressure; Carotid Intima-Media Thickness; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Folic Acid; Humans; Hypertension; Lipids; Male; Middle Aged; Pravastatin; Stroke, Lacunar | 2021 |
Pravastatin therapy during preeclampsia prevents long-term adverse health effects in mice.
Topics: Animals; Cardiovascular Diseases; Disease Models, Animal; Endothelin-1; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Male; Mice; Mice, Inbred C57BL; Placenta; Pravastatin; Pre-Eclampsia; Pregnancy; Risk Factors; Vascular Remodeling | 2018 |
Clinical features related to statin-associated muscle symptoms.
Topics: Aged; Atorvastatin; Female; Heart Diseases; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Logistic Models; Lovastatin; Male; Medical History Taking; Middle Aged; Muscle Weakness; Muscular Diseases; Myalgia; Obesity; Odds Ratio; Pravastatin; Retrospective Studies; Rhabdomyolysis; Risk Factors; Rosuvastatin Calcium; Simvastatin; Smoking; White People | 2019 |
Factors associated with statin selection among privately insured commercial and Medicare patients.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Atorvastatin; Cardiovascular Diseases; Cohort Studies; Comorbidity; Drug Interactions; Dyslipidemias; Female; Fluorobenzenes; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Insurance, Health; Male; Medicare; Middle Aged; Pravastatin; Pyrimidines; Pyrroles; Retrospective Studies; Rosuvastatin Calcium; Sex Factors; Simvastatin; Sulfonamides; United States; Young Adult | 2013 |
Pravastatin attenuates hypertension, oxidative stress, and angiogenic imbalance in rat model of placental ischemia-induced hypertension.
Topics: Animals; Blood Pressure; Cells, Cultured; Disease Models, Animal; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Ischemia; Neovascularization, Physiologic; Oxidative Stress; Placenta; Pravastatin; Pre-Eclampsia; Pregnancy; Rats; Rats, Sprague-Dawley; Thiobarbituric Acid Reactive Substances; Trophoblasts; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1 | 2013 |
Long-term statin administration to dams on high-fat diet protects not only them but also their offspring from cardiovascular risk.
Topics: Animals; C-Reactive Protein; Cardiovascular Diseases; Diet, High-Fat; Female; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypertension; Kidney; Lactation; Lipids; Male; Maternal Nutritional Physiological Phenomena; Mice; Mice, Inbred C57BL; Pravastatin; Pregnancy; Prenatal Exposure Delayed Effects; Random Allocation; Weaning | 2013 |
What does ALLHAT tell us about dyslipidemia from the hypertension specialist perspective?
Topics: Anticholesteremic Agents; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypertension; Male; Pravastatin | 2013 |
Lipid-lowering in African Americans in ALLHAT-optimism bias?
Topics: Anticholesteremic Agents; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypertension; Male; Pravastatin | 2013 |
Author response to lipid-lowering in African Americans in ALLHAT-optimism bias?
Topics: Anticholesteremic Agents; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypertension; Male; Pravastatin | 2013 |
The effect of simvastatin and pravastatin on arterial blood pressure, baroreflex, vasoconstrictor, and hypertensive effects of angiotensin II in Sprague-Dawley rats.
Topics: Angiotensin II; Animals; Baroreflex; Blood Pressure; Drug Synergism; Heart Rate; Hypertension; Male; Pravastatin; Rats; Rats, Sprague-Dawley; Simvastatin; Vasoconstriction | 2014 |
[Erythrocyte aggregation in patients with arterial hypertension and dyslipidemia treated with pravastatin].
Topics: Anticholesteremic Agents; Antihypertensive Agents; Biological Availability; Drug Monitoring; Dyslipidemias; Enalapril; Erythrocyte Aggregation; Erythrocyte Membrane; Erythrocytes; Female; Humans; Hypertension; Lipid Peroxidation; Male; Middle Aged; Pravastatin; Severity of Illness Index; Treatment Outcome | 2014 |
Statin-associated muscle symptoms and SLCO1B1 rs4149056 genotype in patients with familial hypercholesterolemia.
Topics: Age Factors; Body Mass Index; Cholesterol, LDL; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Hypertension; Liver-Specific Organic Anion Transporter 1; Male; Middle Aged; Myalgia; Odds Ratio; Pravastatin; Rosuvastatin Calcium; Simvastatin | 2016 |
Statins and blood pressure.
Topics: Aged; Blood Pressure Determination; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Pravastatin; Randomized Controlled Trials as Topic | 2008 |
Risk factors for stroke and lipid-lowering effect of pravastatin on the risk of stroke in Japanese patients with hypercholesterolemia: analysis of data from the MEGA Study, a large randomized controlled trial.
Topics: Adult; Aged; Alcohol Drinking; Cholesterol; Combined Modality Therapy; Comorbidity; Diabetes Mellitus; Female; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypertension; Incidence; Japan; Lipoprotein(a); Male; Middle Aged; Obesity; Pravastatin; Proportional Hazards Models; Randomized Controlled Trials as Topic; Risk Factors; Sex Factors; Smoking; Stroke | 2009 |
Combination treatment to prevent atherosclerosis.
Topics: Anticholesteremic Agents; Antihypertensive Agents; Atherosclerosis; Blood Pressure; Drug Therapy, Combination; Dyslipidemias; Humans; Hypertension; Pravastatin | 2009 |
Chronic treatment with pravastatin prevents early cardiovascular changes in spontaneously hypertensive rats.
Topics: Animals; Blood Pressure; Cardiovascular Diseases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Hypertrophy, Left Ventricular; Lipid Peroxidation; Male; Nitric Oxide; Nitroprusside; Oxidative Stress; Phenylephrine; Pravastatin; Rats; Rats, Inbred SHR; Superoxides | 2009 |
Angiotensin II receptor blocker and statins lower elevated levels of osteopontin in essential hypertension--results from the EUTOPIA trial.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Atherosclerosis; Biomarkers; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Imidazoles; Male; Middle Aged; Osteopontin; Pravastatin; Prospective Studies; Randomized Controlled Trials as Topic; Tetrazoles | 2010 |
Effect of pravastatin on nephroprotection in deoxycorticosterone acetate-salt hypertensive rats.
Topics: Animals; Base Sequence; Blood Pressure; Desoxycorticosterone; DNA Primers; Endothelin-1; Hypertension; Immunohistochemistry; Kidney; Male; Organ Size; Pravastatin; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sodium Chloride, Dietary | 2009 |
Statins promote the growth of experimentally induced cerebral aneurysms in estrogen-deficient rats.
Topics: Animals; Apoptosis; Brain; Cells, Cultured; Disease Models, Animal; Endothelial Cells; Estrogens; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Intracranial Aneurysm; Nitric Oxide Synthase Type III; Pravastatin; Rats; Rats, Sprague-Dawley; Simvastatin | 2011 |
Pravastatin and Aspirin.
Topics: Advisory Committees; Aspirin; Cardiovascular Agents; Cardiovascular Diseases; Drug Packaging; Drug Therapy, Combination; Humans; Hypertension; Pravastatin | 2002 |
The ALLHAT lipid lowering trial--less is less.
Topics: Anticholesteremic Agents; Cardiovascular Diseases; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypertension; Pravastatin | 2002 |
Statin fails to meet expectations.
Topics: Cholesterol, LDL; Clinical Trials as Topic; Coronary Disease; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Pravastatin; Treatment Failure | 2003 |
High praise for an old standby. Low-cost diuretics excel in combating high blood pressure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Anticholesteremic Agents; Antihypertensive Agents; Chlorthalidone; Clinical Trials as Topic; Diuretics; Humans; Hypertension; Pravastatin | 2003 |
Statins: new data in secondary prevention and diabetes. Pravastatin and simvastatin are the best-assessed statins.
Topics: Aged; Anticholesteremic Agents; Clinical Trials as Topic; Coronary Disease; Diabetes Mellitus; Drug Evaluation; Heptanoic Acids; Humans; Hypertension; Pravastatin; Pyrroles; Rhabdomyolysis; Simvastatin; Stroke; Treatment Outcome | 2003 |
[Primary prevention of stroke. What helps--what does not help? The guidelines of the German Society of Neurology briefly summarized].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Aged; Alcohol Drinking; Anticholesteremic Agents; Anticoagulants; Antihypertensive Agents; Arrhythmias, Cardiac; Aspirin; Atenolol; Atrial Fibrillation; Carotid Artery, Internal; Carotid Stenosis; Chlorthalidone; Clinical Trials as Topic; Diabetes Complications; Diuretics; Doxazosin; Female; Fibrinolytic Agents; Hormone Replacement Therapy; Humans; Hyperlipidemias; Hypertension; Hypolipidemic Agents; Life Style; Losartan; Male; Neurology; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Pravastatin; Primary Prevention; Risk Factors; Simvastatin; Smoking; Societies, Medical; Stroke | 2003 |
[Results of clinical evidence: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)].
Topics: Anticholesteremic Agents; Antihypertensive Agents; Chlorthalidone; Diuretics; Humans; Hypertension; Middle Aged; Multicenter Studies as Topic; Myocardial Ischemia; North America; Pravastatin; Randomized Controlled Trials as Topic | 2003 |
Statins induce the regression of left ventricular mass in patients with angina.
Topics: Aged; Angina Pectoris; Calcium Channel Blockers; Cardiomegaly; Case-Control Studies; Constriction, Pathologic; Drug Evaluation; Female; Heart Ventricles; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Male; Middle Aged; Pravastatin; Retrospective Studies; Simvastatin | 2004 |
Statin-associated exacerbation of myasthenia gravis.
Topics: Atorvastatin; Cytokines; Dysarthria; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypertension; Lovastatin; Male; Middle Aged; Mitochondria; Models, Neurological; Muscular Diseases; Myasthenia Gravis; Neural Conduction; Pravastatin; Pyridostigmine Bromide; Pyrroles; Simvastatin; Th2 Cells; Ubiquinone | 2004 |
Beneficial effect of simvastatin and pravastatin treatment on adverse cardiac remodelling and glomeruli loss in spontaneously hypertensive rats.
Topics: Animals; Blood Pressure; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Kidney Glomerulus; Male; Myocardium; Myocytes, Cardiac; Pravastatin; Rats; Rats, Inbred SHR; Simvastatin; Triglycerides; Ventricular Remodeling | 2005 |
Effect of pravastatin on development of left ventricular hypertrophy in spontaneously hypertensive rats.
Topics: Animals; Body Weight; Cardiac Pacing, Artificial; Endothelin-1; Hemodynamics; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Hypertrophy, Left Ventricular; Immunohistochemistry; Male; Myocardium; Organ Size; Pravastatin; Rats; Rats, Inbred SHR; RNA, Messenger; Ventricular Function | 2005 |
Statins for high-risk patients without heart disease or high cholesterol.
Topics: Atorvastatin; Cholesterol, LDL; Clinical Trials as Topic; Coronary Disease; Diabetes Mellitus, Type 2; Drug Interactions; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Pravastatin; Pyrroles; Simvastatin; Stroke | 2006 |
Renoprotective effect of pravastatin in salt-loaded Dahl salt-sensitive rats.
Topics: Animals; Blood Pressure; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Kidney; Male; Nephrosclerosis; Oxidative Stress; Pravastatin; Rats; Rats, Inbred Dahl | 2005 |
Statins and cerebral vasomotor reactivity: implications for a new therapy?
Topics: Adult; Animals; Arginine; Atorvastatin; Brain Ischemia; Cerebrovascular Circulation; Clinical Trials, Phase II as Topic; Endothelium, Vascular; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypertension; Intracranial Aneurysm; Mice; Middle Cerebral Artery; Nitric Oxide; Pravastatin; Pyrroles; Randomized Controlled Trials as Topic; Research Design; Risk Factors; Simvastatin; Stroke; Subarachnoid Hemorrhage; Ultrasonography, Doppler, Transcranial; Vasodilation; Vasomotor System; Vasospasm, Intracranial | 2006 |
Pravastatin enhances beneficial effects of olmesartan on vascular injury of salt-sensitive hypertensive rats, via pleiotropic effects.
Topics: Animals; Disease Models, Animal; Drug Interactions; Drug Therapy, Combination; Endothelium, Vascular; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Imidazoles; Nitric Oxide; Oxidation-Reduction; Oxidative Stress; Pravastatin; Rats; Rats, Inbred Dahl; Reference Values; Risk Factors; Sensitivity and Specificity; Sodium Chloride, Dietary; Tetrazoles; Vascular Diseases | 2007 |
Absence of an interaction between the angiotensin-converting enzyme insertion-deletion polymorphism and pravastatin on cardiovascular disease in high-risk hypertensive patients: the Genetics of Hypertension-Associated Treatment (GenHAT) study.
Topics: Aged; Antihypertensive Agents; Coronary Disease; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Male; Middle Aged; Myocardial Infarction; Peptidyl-Dipeptidase A; Pharmacogenetics; Polymorphism, Genetic; Pravastatin; Proportional Hazards Models; Randomized Controlled Trials as Topic; Risk Assessment | 2007 |
Nitropravastatin stimulates reparative neovascularisation and improves recovery from limb Ischaemia in type-1 diabetic mice.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Hindlimb; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Ischemia; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Neovascularization, Physiologic; Nitrates; Nitric Oxide; Nitric Oxide Synthase Type III; Pravastatin | 2007 |
Pravastatin attenuates left ventricular remodeling and diastolic dysfunction in angiotensin II-induced hypertensive mice.
Topics: Angiotensin II; Animals; Blood Pressure; Cholesterol; Disease Models, Animal; Fibrosis; Gene Expression Regulation; Heart Failure, Diastolic; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Hypertrophy, Left Ventricular; Male; Mice; Mice, Inbred C57BL; Pravastatin; rho-Associated Kinases; Ventricular Remodeling | 2008 |
Statin treatment in hypercholesterolemic pregnant mice reduces cardiovascular risk factors in their offspring.
Topics: Animals; Anticholesteremic Agents; Blood Pressure; Cholesterol, Dietary; Cholesterol, HDL; Cholesterol, LDL; Female; Hypercholesterolemia; Hypertension; Mice; Mice, Inbred C57BL; Motor Activity; Pravastatin; Pregnancy; Prenatal Exposure Delayed Effects; Risk Factors | 2008 |
Pravastatin-associated myopathy. Report of a case.
Topics: Acute Disease; Aged; Biopsy; Diabetes Mellitus, Type 2; Humans; Hypercholesterolemia; Hypertension; Male; Muscle, Skeletal; Muscular Diseases; Myositis; Pravastatin | 1995 |
Effects of pravastatin in dyslipidaemic patients with and without hypertension.
Topics: Aged; Antihypertensive Agents; Blood Glucose; Cholesterol; Drug Therapy, Combination; Humans; Hypercholesterolemia; Hypertension; Insulin; Middle Aged; Pravastatin; Triglycerides | 1993 |
Pravastatin affects blood pressure and vascular reactivity.
Topics: Animals; Anticholesteremic Agents; Aorta, Thoracic; Blood Pressure; Cholesterol; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Male; Mevalonic Acid; Norepinephrine; Pravastatin; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Vasoconstriction | 1996 |
Peripheral perfusion and tissue oxygenation improvement induced by antihypertensive medication combined with lipoidoproteinosis treatment.
Topics: Anticholesteremic Agents; Antihypertensive Agents; Drug Therapy, Combination; Exercise Test; Female; Fosinopril; Humans; Hypertension; Lipoid Proteinosis of Urbach and Wiethe; Male; Microcirculation; Middle Aged; Oxygen; Pravastatin | 1997 |
Effects of lipid-lowering agents in the Dahl salt-sensitive rat.
Topics: Animals; Blood Pressure; Cholesterol; Clofibrate; Cytochrome P-450 CYP4A; Cytochrome P-450 Enzyme System; Diet, Sodium-Restricted; Enzyme Induction; Female; Fenofibrate; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Hypolipidemic Agents; Kidney; Kidney Glomerulus; Male; Mixed Function Oxygenases; Pravastatin; Proteinuria; Rats; Rats, Inbred Strains; Sodium, Dietary; Triglycerides; Weight Gain | 1998 |
The management of hypercholesterolaemia in patients with coronary artery disease referred for coronary angiography.
Topics: Aged; Anticholesteremic Agents; Cholesterol; Cohort Studies; Coronary Angiography; Coronary Disease; Data Interpretation, Statistical; Diabetes Complications; Female; Follow-Up Studies; Humans; Hypercholesterolemia; Hypertension; Male; Middle Aged; Pravastatin; Risk Factors; Simvastatin; Smoking; Treatment Outcome | 1998 |
Laser-assisted optical rotational red cell analyzer (LORCA) in clinical practice. Hemorheological kinetics and tissue oxygenation.
Topics: Amlodipine; Anticholesteremic Agents; Antihypertensive Agents; Calcium Channel Blockers; Erythrocytes; Female; Hemorheology; Humans; Hypercholesterolemia; Hypertension; Hypertriglyceridemia; Kinetics; Lasers; Male; Middle Aged; Oxygen; Pravastatin | 1999 |
Clinical trials and clinical practice--bridging the gaps in type 2 diabetes. An evidence-based approach to risk factor modification in type 2 diabetes.
Topics: Anticholesteremic Agents; Antihypertensive Agents; Atenolol; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Evidence-Based Medicine; Humans; Hypertension; Hypoglycemic Agents; Metformin; Myocardial Ischemia; Practice Guidelines as Topic; Pravastatin; Risk Factors | 2000 |
Pravastatin, blood pressure, and stroke.
Topics: Anticholesteremic Agents; Arteries; Blood Pressure; Clinical Trials as Topic; Compliance; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Pravastatin; Stroke; Veins | 2000 |
Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cardiovascular Diseases; Cholesterol; Cross-Sectional Studies; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Hypolipidemic Agents; Lovastatin; Male; Middle Aged; Pravastatin; Prevalence; Retrospective Studies; Risk Factors; Treatment Outcome | 2000 |
Improvement of endothelial function in insulin-resistant carotid arteries treated with pravastatin.
Topics: Animals; Carotid Stenosis; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Endothelium, Vascular; Hypertension; Insulin Resistance; Male; Nitric Oxide; Pravastatin; Rats; Rats, Sprague-Dawley; Risk Factors; Stroke; Vascular Resistance | 2001 |
Simvastatin and atorvastatin enhance hypotensive effect of diltiazem in rats.
Topics: Animals; Antihypertensive Agents; Atorvastatin; Blood Pressure; Diltiazem; Drug Synergism; Drug Therapy, Combination; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Male; Pravastatin; Pyrroles; Rats; Rats, Sprague-Dawley | 2001 |
Acanthopanax divaricatus var. chiisanensis reduces blood pressure via the endothelial nitric oxide synthase pathway in the spontaneously hypertensive rat model.
Topics: Animals; Antihypertensive Agents; Aorta; Blood Pressure; Eleutherococcus; Endothelium, Vascular; Furans; Glucosides; Humans; Hypertension; Lignans; Male; Nitric Oxide; Nitric Oxide Synthase; Phytotherapy; Plant Extracts; Rats, Inbred SHR; Rats, Inbred WKY; Signal Transduction; Umbilical Veins; Vasodilation | 2014 |